StonvexLoading…
StonvexStonvexStonvexCore line items from BCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.26B | $5.01B | $4.87B | $4.54B |
Operating Income | $585.50M | $453.00M | $425.20M | $361.30M |
Net Income | $199.70M | $162.90M | $87.70M | $170.60M |
EPS (Diluted) | $4.69 | $3.63 | $1.87 | $3.57 |
Total Assets | $7.34B | $6.62B | $6.60B | $6.37B |
Total Liabilities | $6.93B | $6.31B | $6.08B | $5.80B |
Cash & Equivalents | $1.73B | $1.40B | $1.18B | $972.00M |
Free Cash Flow OCF − CapEx | $436.40M | $203.50M | $499.70M | $297.30M |
Shares Outstanding | 41.10M | 42.90M | 44.50M | 46.30M |